日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2021/07/30 | 日証協 | 9,284株 | -5.11% | 1,200株 | +500% | 37,705株 | +0.67% | 12,233株 | +19.6% |
| 2021/07/21 | 日証協 | 9,784株 | -6.68% | 200株 | -88.73% | 37,453株 | -5.27% | 10,228株 | -24.96% |
| 2021/07/16 | 日証協 | 10,484株 | +19.01% | 1,775株 | -42.74% | 39,538株 | +19.71% | 13,630株 | -23.17% |
| 2021/07/09 | 日証協 | 8,809株 | -34.73% | 3,100株 | +121.43% | 33,027株 | -19.17% | 17,741株 | +271.54% |
| 2021/07/02 | 日証協 | 13,496株 | +5.47% | 1,400株 | +180% | 40,858株 | -0.25% | 4,775株 | +23.61% |
| 2021/06/25 | 日証協 | 12,796株 | -21.47% | 500株 | -91.93% | 40,962株 | -7.48% | 3,863株 | -67.45% |
| 2021/06/18 | 日証協 | 16,295株 | +27.34% | 6,199株 | -22.52% | 44,276株 | +4.21% | 11,868株 | -66.05% |
| 2021/06/11 | 日証協 | 12,796株 | +23.1% | 8,001株 | +7821.78% | 42,488株 | +90.64% | 34,959株 | +4643.42% |
| 2021/06/04 | 日証協 | 10,395株 | -4.58% | 101株 | -79.8% | 22,287株 | -3.86% | 737株 | +83.79% |
| 2021/05/28 | 日証協 | 10,894株 | +3.81% | 500株 | +150% | 23,181株 | -0.86% | 401株 | -88.52% |
| 2021/05/21 | 日証協 | 10,494株 | +1.94% | 200株 | 0% | 23,381株 | +1.3% | 3,494株 | +150.11% |
| 2021/05/14 | 日証協 | 10,294株 | 0% | 0株 | 0% | 23,081株 | +0.85% | 1,397株 | +15.84% |
| 2021/05/07 | 日証協 | 10,294株 | 0% | 0株 | -100% | 22,886株 | +0.88% | 1,206株 | +8.84% |
| 2021/04/30 | 日証協 | 10,294株 | -0.96% | 199株 | -71.53% | 22,686株 | +0.46% | 1,108株 | -60.33% |
| 2021/04/23 | 日証協 | 10,394株 | +2.97% | 699株 | +16.69% | 22,581株 | -4.65% | 2,793株 | -59.53% |
| 2021/04/16 | 日証協 | 10,094株 | -12.94% | 599株 | -62.54% | 23,681株 | -4.82% | 6,901株 | +146.82% |
| 2021/04/09 | 日証協 | 11,594株 | -36.37% | 1,599株 | -81.83% | 24,881株 | -23.67% | 2,796株 | -90.38% |
| 2021/04/02 | 日証協 | 18,222株 | -6.66% | 8,798株 | -0.01% | 32,595株 | -29.28% | 29,057株 | +79.07% |
| 2021/03/26 | 日証協 | 19,522株 | +7.73% | 8,799株 | +23.96% | 46,093株 | +19.52% | 16,227株 | -15.92% |
※株式分割は考慮していませんのでご注意ください。